NCT04721587

Brief Summary

Hysteroscopy is a minimally invasive endoscopic technique that allows direct visualization of the uterine cavity and constitutes the gold standard for the diagnosis and treatment of most intrauterine pathology, such as heavy menstrual bleeding, fibroids, endometrial polyps, uterine malformations, etc. The "see and treat" strategy allows diagnosis and treatment in the same surgical act, and gives the technique a high resolution capacity, reducing the number of procedures the patient must undergo. The technological development of instruments has made it possible to have small-caliber endoscopic systems that have made this technique possible in an outpatient setting. Outpatient management allows patients to avoid the possible risks and inconveniences associated with the surgical environment, such as the waiting list and the need for anesthesia, as well as an earlier return to their activities of daily life. Despite the high resolution rates, a not inconsiderable percentage of women experience anxiety or pain during outpatient hysteroscopy, and this is the leading cause of treatment failure. In order to improve the tolerance and comfort of the patient, the usefulness of various strategies, both pharmacological and non-pharmacological, has been evaluated for pain reduction, with different results. Virtual Reality (VR) has been used successfully to reduce perceived pain in various procedures such as chronic pain, burns, dental processes, chronic pruritus or venipuncture. There is no published study to our knowledge that evaluates the usefulness of VR in reducing the levels of anxiety and pain perceived during a hysteroscopic procedure. The working hypothesis to be evaluated with this study is that the use of a VR device with reproduction of relaxing and distraction environments reduces the perception of pain and anxiety of the patient during an outpatient hysteroscopy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 18, 2020

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

December 11, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 22, 2021

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

December 20, 2023

Status Verified

January 1, 2021

Enrollment Period

3.4 years

First QC Date

December 11, 2020

Last Update Submit

December 19, 2023

Conditions

Keywords

HysteroscopyPainVirtual RealityAnxiety

Outcome Measures

Primary Outcomes (1)

  • Pain score

    Decrease of 1 point or more in the level of pain measured by an 11-point visual analog scale, a validity scale that comprises 11 consecutive values from 0 to 10, with "0" corresponding to no pain and "10" to worst pain imaginable.

    Intraprocedure

Secondary Outcomes (3)

  • Heart Rate

    Intraprocedure

  • Blood Pressure

    Intraprocedure

  • Skin conductace

    Intraprocedure

Study Arms (2)

Standard of care

NO INTERVENTION

Office hysteroscopy performed as the standard of care of our Hospital

Virtual Reality

EXPERIMENTAL

Office hysteroscopy with the use of VR environment (preprocedure and during procedure)

Device: Virtual Reality

Interventions

The patients of the VR Group will be subjected to the same hysteroscopy technique as the Standard of Care Group, but additionally a VR device will be applied where a distraction VR environment ("Underwater Game") will be reproduced during the exploration

Virtual Reality

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being over 18 years
  • Understand and accept the study procedures
  • Sign the informed consent.
  • Indication of outpatient hysteroscopy according to the care protocols of the center
  • Not taking drugs for the treatment of anxiety.

You may not qualify if:

  • Not being able to understand the nature of the study and / or the procedures to be followed
  • Not signing the informed consent
  • Be under the age of 18
  • Pregnancy
  • Being diagnosed with anxiety disorder or being treated with anxiolytics
  • Patients suffering from vertigo
  • Patients with epilepsy
  • Active ear infection
  • Patients with diagnosed hypertension
  • Patients with cardiovascular disease
  • Patients with psychosis or severe mental illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital de la Santa Creu i Sant Pau

Barcelona, Spain

Location

MeSH Terms

Conditions

Acute PainAnxiety DisordersPain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Officials

  • Josep Estadella Tarriel

    Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 11, 2020

First Posted

January 22, 2021

Study Start

February 18, 2020

Primary Completion

June 30, 2023

Study Completion

June 30, 2023

Last Updated

December 20, 2023

Record last verified: 2021-01

Locations